| Sources | Names Used |
|---|---|
| CTRPv2 | ML334 diastereomer |
| PharmacoGx | ML334 diastereomer |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OR10V1 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-05 |
| mRNA | THBS2 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-05 |
| mRNA | GDF15 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-05 |
| mRNA | GBAS | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-05 |
| mRNA | AXIN2 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-05 |
| mRNA | HAS1 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | TAF2 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | TREH | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | PRUNE2 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | SLC36A2 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
